0001209191-18-050747.txt : 20180913 0001209191-18-050747.hdr.sgml : 20180913 20180913083657 ACCESSION NUMBER: 0001209191-18-050747 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180913 DATE AS OF CHANGE: 20180913 EFFECTIVENESS DATE: 20180913 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Little Pharma, Inc. CENTRAL INDEX KEY: 0001752787 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-321225 FILM NUMBER: 181068008 BUSINESS ADDRESS: STREET 1: 170 AMSTERDAM AVENUE STREET 2: #6C CITY: NEW YORK STATE: NY ZIP: 10023 BUSINESS PHONE: 856-816-6660 MAIL ADDRESS: STREET 1: 170 AMSTERDAM AVENUE STREET 2: #6C CITY: NEW YORK STATE: NY ZIP: 10023 D 1 primary_doc.xml X0708 D LIVE 0001752787 Little Pharma, Inc. 170 Amsterdam Avenue #6C New York NY NEW YORK 10023 856-816-6660 DELAWARE None None Corporation true 2018 Ethan Lauf Goldstein 170 Amsterdam Avenue #6C New York NY NEW YORK 10023 Executive Officer Director Promoter Pharmaceuticals Decline to Disclose 06b false 2018-08-31 false true true true Issuance of Convertible Promissory Notes and underlying Conversion Shares. false 0 1000000 557500 442500 false 19 0 0 0 false Little Pharma, Inc. /s/ Ethan Lauf Goldstein Ethan Lauf Goldstein President and Chief Executive Officer 2018-09-12